Monkeypox : Don urges NCDC to begin clinical trial of MSAMS

WHO to decide global health status of monkeypox Thursday

There are now a total of 1,900 confirmed cases in 39 countries across the globe, including 36 confirmed cases in Nigeria.

Maduike Ezeibe, a professor of Virology, has called on Nigeria Centre for Disease Control (NCDC) to verify the efficacy of Medicinal Synthetic Aluminum Magnesium Silicate (MSAMS) on monkeypox, through clinical trials in order to save lives. MSAMS is a mineral-based drug formulated by Ezeibe, whic

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```